The invention relates to a solid pharmaceutical preparation containing one
or more solid carriers and/or excipients and an active substance selected
from among the Monoamine Neurotransmitter Re-uptake Inhibitors which have
a 2,3-disubstituted tropane structure, the preparation thereof and use
thereof for preparing a pharmaceutical composition for the treatment or
prevention of central-nervous diseases or disorders.
